Skip to content

Application of ultrasound-guided rhomboid intercostal nerve block in modified radical mastectomy of breast cancer

Application of ultrasound-guided rhomboid intercostal nerve block in modified radical mastectomy of breast cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045346
Enrollment
Unknown
Registered
2021-04-13
Start date
2021-04-14
Completion date
Unknown
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Control group:None
Experimental group R1:0.3% ropivacaine rhomboid intercostal nerve block
Experimental group R2:0.4% ropivacaine rhomboid intercostal nerve block
Experimental group R3:0.5% ropivacaine rhomboid intercostal nerve block

Sponsors

Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Unilateral modified radical mastectomy for breast cancer was performed in the First Hospital of Jiaxing City. A total of 90 patients, aged from 18 to 80 years, ASA I~III grade were treated.

Exclusion criteria

Exclusion criteria: 1.Shock or coma; 2.Abnormal heart, lung, liver, kidney and coagulation function; 3.Intended block area infection, severe nerve injury of the block side limb; 4.Patients with a history of analgesic drugs for chronic pain, a history of psychotropic substance use, a history of radiotherapy and chemotherapy, and contraindications to NSAIDs; 5.Patients with allergies to local anesthetics such as lidocaine, ropivacaine and general anesthesia; 6.Patients and their families refused surgical anesthesia.

Design outcomes

Primary

MeasureTime frame
Numeric rating scale score;Opioid use;

Secondary

MeasureTime frame
Time of the first pain;Incidence of nausea and vomiting;Analgesic remedy;

Countries

China

Contacts

Public ContactDeng Wei

Affiliated Hospital of Jiaxing University

dengwei1992868@163.com+86 19884340796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026